8-K current report · filed Oct 27, 2026

aTYR PHARMA INC (ATYR) 8-K Current Report: October 27, 2026

Item 5.03ATYR overview

Short answer

aTYR PHARMA INC (ATYR) filed an 8-K current report with the SEC on October 27, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). 1-for-40 reverse split effective 5:00 p.m. ET October 28, 2026.

aTYR PHARMA INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.03 · Amendments to Articles of Incorporation or Bylaws

  • 1-for-40 reverse split effective 5:00 p.m. ET October 28, 2026
  • Shares outstanding reduced from approximately 100.5 million to 2.5 million
  • Authorized shares unchanged at 340 million, increasing potential post-split issuance capacity
  • Options, RSUs and warrants adjusted proportionately, with higher exercise prices
  • Nasdaq Capital Market trading under ATYR on split-adjusted basis October 29, 2026, new CUSIP 002120301

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other aTYR PHARMA INC 8-K filings

Get the next ATYR 8-K as it lands

Follow ATYR for push alerts, or ask the research agent what this filing means.